Indication
Tufted Hemangioma
3 clinical trials
2 products
1 drug
Clinical trial
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma：a Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2024-08-30
Product
TacrolimusClinical trial
A Randomized Phase 2 Study of Vincristine Versus Sirolimus to Treat High Risk Kaposiform Hemangioendothelioma (KHE).Status: Terminated, Estimated PCD: 2019-10-02
Drug
VincristineProduct
SirolimusClinical trial
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-11-01